NCT00002045View on ClinicalTrials.gov

A Prospective Double-Blind Study of Retrovir in Early HIV Infection

NACompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Zidovudine

Trial Locations (1)

27709

Glaxo Wellcome Inc, Research Triangle Park

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Glaxo Wellcome

INDUSTRY

NCT00002045 - A Prospective Double-Blind Study of Retrovir in Early HIV Infection | Biotech Hunter | Biotech Hunter